286 related articles for article (PubMed ID: 20861190)
1. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.
Reyes-Reyes EM; Teng Y; Bates PJ
Cancer Res; 2010 Nov; 70(21):8617-29. PubMed ID: 20861190
[TBL] [Abstract][Full Text] [Related]
2. AS1411 binds to nucleolin via its parallel structure and disrupts the exos-miRNA-27a-mediated reciprocal activation loop between glioma and astrocytes.
Sun X; Zhang W; Gou C; Wang X; Wang X; Shao X; Chen X; Chen Z
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167211. PubMed ID: 38701957
[TBL] [Abstract][Full Text] [Related]
3. Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer.
Wang Y; Chen X; Tian B; Liu J; Yang L; Zeng L; Chen T; Hong A; Wang X
Theranostics; 2017; 7(5):1360-1372. PubMed ID: 28435471
[TBL] [Abstract][Full Text] [Related]
4. Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells.
Esawi E; Alshaer W; Mahmoud IS; Alqudah DA; Azab B; Awidi A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884745
[TBL] [Abstract][Full Text] [Related]
5. Study of the Function of G-Rich Aptamers Selected for Lung Adenocarcinoma.
Hu J; Zhao Z; Liu Q; Ye M; Hu B; Wang J; Tan W
Chem Asian J; 2015 Jul; 10(7):1519-25. PubMed ID: 25864879
[TBL] [Abstract][Full Text] [Related]
6. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.
Bates PJ; Laber DA; Miller DM; Thomas SD; Trent JO
Exp Mol Pathol; 2009 Jun; 86(3):151-64. PubMed ID: 19454272
[TBL] [Abstract][Full Text] [Related]
7. Anti-nucleolin aptamer AS1411: an advancing therapeutic.
Van den Avont A; Sharma-Walia N
Front Mol Biosci; 2023; 10():1217769. PubMed ID: 37808518
[TBL] [Abstract][Full Text] [Related]
8. Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets.
Murphy EM; Centner CS; Bates PJ; Malik MT; Kopechek JA
PLoS One; 2020; 15(5):e0233466. PubMed ID: 32437399
[TBL] [Abstract][Full Text] [Related]
9. Direct investigations of interactions between nucleolins and aptamers on pancreatic cancer and normal cells by atomic force microscopy.
Li X; Chen L; Kong S; Zhong H; Jiang F; Zhao W
Ultramicroscopy; 2024 May; 263():113986. PubMed ID: 38762964
[TBL] [Abstract][Full Text] [Related]
10. Insights on the molecular mechanisms of cytotoxicity induced by AS1411 linked to folate-functionalized DNA nanocages in cancer cells.
Unida V; Mangano E; Camboni T; Consolandi C; Desideri A; Severgnini M; Cifola I; Biocca S
Nanomedicine; 2023 Nov; 54():102710. PubMed ID: 37734452
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-mediated selective delivery of a cytotoxic cationic NHC-Au(i) complex to cancer cells.
Niu W; Teng IT; Chen X; Tan W; Veige AS
Dalton Trans; 2017 Dec; 47(1):120-126. PubMed ID: 29192701
[TBL] [Abstract][Full Text] [Related]
12. "Light-On" Fluorescent Nanoprobes for Monitoring Dynamic Distribution of Cellular Nucleolin During Pyroptosis.
Kong J; Ju X; Qi G; Wang J; Diao X; Wang B; Zhang C; Li J; Jin Y
Anal Chem; 2024 Jan; 96(2):926-933. PubMed ID: 38158373
[TBL] [Abstract][Full Text] [Related]
13. AS1411-functionalized delivery nanosystems for targeted cancer therapy.
Kozani PS; Kozani PS; Malik MT
Explor Med; 2021; 2():146-166. PubMed ID: 34723284
[TBL] [Abstract][Full Text] [Related]
14. Nucleolin/C23 is a negative regulator of hydrogen peroxide-induced apoptosis in HUVECs.
Zhang B; Wang H; Jiang B; Liang P; Liu M; Deng G; Xiao X
Cell Stress Chaperones; 2010 May; 15(3):249-57. PubMed ID: 19757191
[TBL] [Abstract][Full Text] [Related]
15. The new face of nucleolin in human melanoma.
Hoja-Łukowicz D; Przybyło M; Pocheć E; Drabik A; Silberring J; Kremser M; Schadendorf D; Laidler P; Lityńska A
Cancer Immunol Immunother; 2009 Sep; 58(9):1471-80. PubMed ID: 19363676
[TBL] [Abstract][Full Text] [Related]
16. Preliminary study on the effect of nucleolin specific aptamer-miRNA let-7d chimera on Janus kinase-2 expression level and activity in gastric cancer (MKN-45) cells.
Ramezanpour M; Daei P; Tabarzad M; Khanaki K; Elmi A; Barati M
Mol Biol Rep; 2019 Feb; 46(1):207-215. PubMed ID: 30415442
[TBL] [Abstract][Full Text] [Related]
17. Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma.
Seo K; Hwang K; Nam KM; Kim MJ; Song YK; Kim CY
Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675227
[TBL] [Abstract][Full Text] [Related]
18. DNA Walker-Regulated Cancer Cell Growth Inhibition.
Li F; Cha TG; Pan J; Ozcelikkale A; Han B; Choi JH
Chembiochem; 2016 Jun; 17(12):1138-41. PubMed ID: 27059426
[TBL] [Abstract][Full Text] [Related]
19. DNA Nanoribbon for Efficient Anti-miRNA Peptide Nucleic Acid Delivery and Synergistic Enhancement of Cancer Cell Apoptosis.
Fu P; Chen H; Ouyang L; Li L; Wang Y; Qian S; Cao Z; Wu K; Chao J; Zheng J
Anal Chem; 2022 Dec; ():. PubMed ID: 36542541
[TBL] [Abstract][Full Text] [Related]
20. A Reconfigurable DNA Framework Nanotube-Assisted Antiangiogenic Therapy.
Li W; Wang Z; Su Q; Chen J; Wu Q; Sun X; Zhu S; Li X; Wei H; Zeng J; Guo L; Zhang C; He J
JACS Au; 2024 Apr; 4(4):1345-1355. PubMed ID: 38665667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
